SPDR S&P Biotech ETF $XBI Stock Position Increased by Marvin & Palmer Associates Inc.

Marvin & Palmer Associates Inc. boosted its position in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 80.1% during the 2nd quarter, according to the company in its most recent disclosure with the SEC. The firm owned 54,286 shares of the exchange traded fund’s stock after buying an additional 24,150 shares during the quarter. SPDR S&P Biotech ETF makes up 5.5% of Marvin & Palmer Associates Inc.’s holdings, making the stock its 9th biggest position. Marvin & Palmer Associates Inc. owned about 0.08% of SPDR S&P Biotech ETF worth $8,591,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in XBI. Wealth Management Partners LLC acquired a new stake in shares of SPDR S&P Biotech ETF in the first quarter worth approximately $547,000. Keystone Investors PTE Ltd. purchased a new stake in shares of SPDR S&P Biotech ETF during the fourth quarter worth approximately $12,022,000. Lalia Capital LLC acquired a new position in SPDR S&P Biotech ETF in the 4th quarter valued at $12,193,000. Jessup Wealth Management Inc acquired a new position in SPDR S&P Biotech ETF in the 4th quarter valued at $1,053,000. Finally, Rockefeller Capital Management L.P. lifted its holdings in SPDR S&P Biotech ETF by 44.4% in the 4th quarter. Rockefeller Capital Management L.P. now owns 236,057 shares of the exchange traded fund’s stock valued at $28,782,000 after purchasing an additional 72,636 shares in the last quarter.

SPDR S&P Biotech ETF Stock Down 3.5%

Shares of XBI opened at $162.38 on Friday. SPDR S&P Biotech ETF has a 52-week low of $89.33 and a 52-week high of $169.89. The firm’s fifty day moving average is $156.78 and its two-hundred day moving average is $139.13. The stock has a market cap of $10.60 billion, a PE ratio of 11.47 and a beta of 0.83.

SPDR S&P Biotech ETF Company Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.